297 related articles for article (PubMed ID: 12017366)
1. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
Braga PC
J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
[TBL] [Abstract][Full Text] [Related]
2. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
Braga PC; Culici M; Dal Sasso M
Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
Crotti D; Rossetti R; Braga PC
Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
Okubo T; Iyobe S; Fujiki Y; Sagai H
Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
[TBL] [Abstract][Full Text] [Related]
7. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
Bejuk D
Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
[TBL] [Abstract][Full Text] [Related]
8. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
Hardy DJ; Hensey DM; Beyer JM; Vojtko C; McDonald EJ; Fernandes PB
Antimicrob Agents Chemother; 1988 Nov; 32(11):1710-9. PubMed ID: 3252753
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of rokitamycin against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Dec; 45(12):1609-21. PubMed ID: 1289579
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Meyran M; Joly B; Derlot E; Morel C
Pathol Biol (Paris); 1990 May; 38(5):407-12. PubMed ID: 2195450
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro potencies of nine new macrolides.
Fernandes PB; Hardy DJ
Drugs Exp Clin Res; 1988; 14(7):445-51. PubMed ID: 3240705
[TBL] [Abstract][Full Text] [Related]
13. [Effects of 14-, 15-, and 16-membered ring macrolides on IL-8 gene expression in BET-1A cells].
Abe S; Inoue S; Otake K; Sada M; Takeda H; Nakamura H
Jpn J Antibiot; 2001 Dec; 54 Suppl C():41-2. PubMed ID: 12627606
[No Abstract] [Full Text] [Related]
14. Chemistry and mode of action of macrolides.
Mazzei T; Mini E; Novelli A; Periti P
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():1-9. PubMed ID: 7683018
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of YM133, a new semisynthesized macrolide.
Terasawa T; Watanabe M; Okubo T; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jul; 35(7):1370-5. PubMed ID: 1929295
[TBL] [Abstract][Full Text] [Related]
16. Effects of erythromycin, clarithromycin and rokitamycin on nifedipine metabolism in rats.
Tsuruta S; Nakamura K; Arimori K; Nakano M
Biol Pharm Bull; 1997 Apr; 20(4):411-6. PubMed ID: 9145220
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory and bactericidal activity of rokitamycin against Helicobacter pylori and morphological alterations.
Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC
J Chemother; 1996 Dec; 8(6):425-31. PubMed ID: 8981182
[TBL] [Abstract][Full Text] [Related]
18. The macrolides: erythromycin, clarithromycin, and azithromycin.
Alvarez-Elcoro S; Enzler MJ
Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
[TBL] [Abstract][Full Text] [Related]
19. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
20. In vitro assessment of rokitamycin against problem gram-positive cocci.
Hamilton-Miller JM; Maple PA
J Chemother; 1992 Feb; 4(1):6-8. PubMed ID: 1403073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
